J8515 — Cabergoline, oral, 0.25 mg
J8515 is a HCPCS Level II code for cabergoline, oral, 0.25 mg. It belongs to the Drugs Administered Other Than Oral Method section. Medicare does not pay it — see the coverage note below before you bill it.
Medicare coverage: Non-covered by Medicare
Medicare does not cover the item or service this code describes.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
Physician fee schedule statusN
Non-covered service. Medicare does not cover it.
Global period: XXX
Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.
Medically Unlikely Edits — units per day
The most units of J8515 Medicare will pay on one date of service. Bill more on a single line and it is denied. The limit is not the same in every setting, so the row that matters is the one matching the claim you are building.
- practitioner
- 0 — never payable MAI 3 — Date of Service Edit: Clinical · CMS Policy
- outpatient
- 0 — never payable MAI 3 — Date of Service Edit: Clinical · CMS Policy
- DME supplier
- 0 — never payable MAI 3 — Date of Service Edit: Clinical · CMS Policy
The adjudication indicator decides whether exceeding the limit is worth appealing at all: MAI 1 is a line edit you can support with documentation, MAI 3 is a date-of-service edit that is also appealable, and MAI 2 is absolute — no documentation overrides it. CMS MUE 2026Q3.
The CMS record for J8515
- Long descriptor
- Cabergoline, oral, 0.25 mg
- Short descriptor
- Cabergoline, oral 0.25mg
- Added
- January 1, 2006
- BETOS
- O1E
- Pricing indicator
- 00 — Not priced by Part B
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Service not separately priced by Part B — not covered, bundled into another service, or used by Part A only.
Codes adjacent to J8515
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J8515 is not quite right, the correct code is very often within a few positions of it.
- J7699Noc drugs, inhalation solution administered through dme
- J7799Noc drugs, other than inhalation drugs, administered through dme
- J7999Compounded drug, not otherwise classified
- J8498Antiemetic drug, rectal/suppository, not otherwise specified
- J8499Prescription drug, oral, non chemotherapeutic, nos
- J8501Aprepitant, oral, 5 mg
- J8502Injection, aprepitant (aponvie), 1 mg
- J8510Busulfan; oral, 2 mg
- J8520Capecitabine, oral, 150 mgterminated
- J8521Capecitabine, oral, 500 mgterminated
- J8522Capecitabine, oral, 50 mg
- J8530Cyclophosphamide; oral, 25 mg
- J8540Dexamethasone, oral, 0.25 mg
- J8541Dexamethasone (hemady), oral, 0.25 mg
- J8560Etoposide; oral, 50 mg
- J8562Fludarabine phosphate, oral, 10 mgterminated
Questions about J8515
What is HCPCS code J8515?
J8515 is a HCPCS Level II code for cabergoline, oral, 0.25 mg. It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J8515?
The CMS HCPCS file marks J8515 as "Non-covered by Medicare". Medicare does not cover the item or service this code describes.
How is J8515 paid under the physician fee schedule?
J8515 carries PFS status code N. Non-covered service. Medicare does not cover it.